Document is current
Any future updates will be listed below
-
Authors
Yan, Allison
Drake, Lara
Hadsall, Sophia
Gaurav, Ahana
Xia, Eric
Mostaghimi, Arash
- License Information
-
More Information
Article History
Received: 6 December 2023
Revised: 9 February 2024
Accepted: 26 April 2024
First Online: 25 May 2024
Declarations
:
: This study protocol was reviewed and approved by Mass General Brigham IRB, approval number 2022P000935.
: Informed consent was not required.
: Dr. Mostaghimi has received consulting fees from Pfizer, hims, Digital Diagnostics, Concert, Lilly, and AbbVie as well as licensing/royalties from Pfizer and Concert; holds equity in and is on the advisory board for hims and Fig. 1; and has participated in clinical trials related to alopecia from Incyte, Lilly, Concert, and Aclaris while serving as associate editor for JAMA Dermatology. None of the other authors have competing interests to disclose.
